Role of leptin in the regulation of glucagon-like peptide-1 secretion

被引:208
作者
Anini, Y
Brubaker, PL
机构
[1] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada
关键词
D O I
10.2337/diabetes.52.2.252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucagon-like peptide-1 (GLP-1), released from intestinal endocrine L cells, is a potent insulinotropic hormone. GLP-1 secretion is diminished in obese patients. Because obesity is linked to abnormal leptin signaling, we hypothesized that leptin may modulate GLP-1 secretion. Leptin significantly stimulated GLP-1 secretion (by up to 250% of control) from fetal rat intestinal cells, a mouse L cell line (GLUTag), and a human L cell line (NCI-H716) in a dose-dependent manner (P < 0.05-0.001). The long form of the leptin receptor was shown to be expressed, and leptin induced the phosphorylation of STAT3 in the three cell types. The leptin receptor was also expressed by rodent and human intestinal L cells, and leptin (1 mg/kg i.p.) significantly stimulated GLP-1 secretion in rats and ob/ob mice. To determine the effect of leptin resistance on GLP-1 secretion, C57BL/6 mice were fed a high-fat (45%) or low-fat (10%) diet for 8 weeks. Mice on the high-fat diet became obese; developed glucose intolerance, hyperinsulinemia, and hyperleptinemia; and were leptin resistant. Mice on the high-fat diet also had twofold lower basal plasma GLP-1 and a diminished GLP-1 response to oral glucose, by 28.5 +/- 5.0% (P < 0.05). These results show for the first time that leptin stimulates GLP-1 secretion from rodent and human intestinal L cells, and they suggest that leptin resistance may account for the decreased levels of GLP-1 found in obese humans.
引用
收藏
页码:252 / 259
页数:8
相关论文
共 58 条
  • [51] Leptin activation of Stat3 in the hypothalamus of wildtype and ob/ob mice but not db/db mice
    Vaisse, C
    Halaas, JL
    Horvath, CM
    Darnell, JE
    Stoffel, M
    Friedman, JM
    [J]. NATURE GENETICS, 1996, 14 (01) : 95 - 97
  • [52] Diet-induced obese mice develop peripheral, but not central, resistance to leptin
    VanHeek, M
    Compton, DS
    France, CF
    Tedesco, RP
    Fawzi, AB
    Graziano, MP
    Sybertz, EJ
    Strader, CD
    Davis, HR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (03) : 385 - 390
  • [53] The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction
    Verdich, C
    Toubro, S
    Buemann, B
    Madsen, JL
    Holst, JJ
    Astrup, A
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (08) : 1206 - 1214
  • [54] Reduced postprandial concentrations of intact biologically active gluccagon-like peptide 1 in type 2 diabetic patients
    Vilsboll, T
    Krarup, T
    Deacon, CF
    Madsbad, S
    Holst, JJ
    [J]. DIABETES, 2001, 50 (03) : 609 - 613
  • [55] Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice
    Wang, Q
    Brubaker, PL
    [J]. DIABETOLOGIA, 2002, 45 (09) : 1263 - 1273
  • [56] GLUCAGON-LIKE PEPTIDE-I (7-37) ACTIONS ON ENDOCRINE PANCREAS
    WEIR, GC
    MOJSOV, S
    HENDRICK, GK
    HABENER, JF
    [J]. DIABETES, 1989, 38 (03) : 338 - 342
  • [57] Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes:: a parallel-group study
    Zander, M
    Madsbad, S
    Madsen, JL
    Holst, JJ
    [J]. LANCET, 2002, 359 (9309) : 824 - 830
  • [58] POSITIONAL CLONING OF THE MOUSE OBESE GENE AND ITS HUMAN HOMOLOG
    ZHANG, YY
    PROENCA, R
    MAFFEI, M
    BARONE, M
    LEOPOLD, L
    FRIEDMAN, JM
    [J]. NATURE, 1994, 372 (6505) : 425 - 432